These Analysts Revise Their Forecasts On GH Research After Q1 Results

Benzinga Earnings

05/15

GH Research PLC (NASDAQ:GHRS) reported a wider-than-expected loss for the first quarter on Thursday.

The company posted quarterly losses of 31 cents per share which missed the analyst consensus estimate of losses of 28 cents per share.

“The first quarter of 2026 marks progress as planned toward our global GH001 Phase 3 pivotal program,” said Dr. Velichka Valcheva, Chief Executive Officer.

GH Research shares fell 3.4% to trade at $21.46 on Friday.

These analysts made changes to their price targets on GH Research following earnings announcement.

Citizens analyst Jason N. Butler maintained GH Research with a Market Outperform and lowered the price target from $42 to $39.
Cantor Fitzgerald analyst Charles Duncan maintained the stock with an Overweight rating and raised the price target from $25 to $35.

Considering buying GHRS stock? Here’s what analysts think:

Photo via Shutterstock

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2635035358"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2635035358\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2635035358?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-15 22:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2635035358","market":"hk","top_or_hot":-1,"title":"These Analysts Revise Their Forecasts On GH Research After Q1 Results","media":"Benzinga Earnings","content":"<html><body><p><strong><a href=\"https://laohu8.com/S/GHRS\">GH Research PLC</a></strong> (NASDAQ:GHRS) reported a wider-than-expected loss for the first quarter on Thursday.</p>\n<p>The company posted quarterly losses of 31 cents per share which missed the analyst consensus estimate of losses of 28 cents per share.</p>\n<p>“The first quarter of 2026 marks progress as planned toward our global GH001 Phase 3 pivotal program,” said Dr. Velichka Valcheva, Chief Executive Officer.</p>\n<p>GH Research shares fell 3.4% to trade at $21.46 on Friday.</p>\n<p>These analysts made changes to their price targets on GH Research following earnings announcement.</p>\n<ul>\n<li>Citizens analyst Jason N. Butler maintained GH Research with a Market Outperform and lowered the price target from $42 to $39.</li>\n<li>Cantor Fitzgerald analyst Charles Duncan maintained the stock with an Overweight rating and raised the price target from $25 to $35.</li>\n</ul>\n<p><strong>Considering buying GHRS stock? Here’s what analysts think:</strong></p>\n<figure><img decoding=\"async\" height=\"435\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-1024x435.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-1024x435.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-300x128.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-768x327.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421.png 1277w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutterstock</em></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These Analysts Revise Their Forecasts On GH Research After Q1 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese Analysts Revise Their Forecasts On GH Research After Q1 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time\">2026-05-15 22:58</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><strong><a href=\"https://laohu8.com/S/GHRS\">GH Research PLC</a></strong> (NASDAQ:GHRS) reported a wider-than-expected loss for the first quarter on Thursday.</p>\n<p>The company posted quarterly losses of 31 cents per share which missed the analyst consensus estimate of losses of 28 cents per share.</p>\n<p>“The first quarter of 2026 marks progress as planned toward our global GH001 Phase 3 pivotal program,” said Dr. Velichka Valcheva, Chief Executive Officer.</p>\n<p>GH Research shares fell 3.4% to trade at $21.46 on Friday.</p>\n<p>These analysts made changes to their price targets on GH Research following earnings announcement.</p>\n<ul>\n<li>Citizens analyst Jason N. Butler maintained GH Research with a Market Outperform and lowered the price target from $42 to $39.</li>\n<li>Cantor Fitzgerald analyst Charles Duncan maintained the stock with an Overweight rating and raised the price target from $25 to $35.</li>\n</ul>\n<p><strong>Considering buying GHRS stock? Here’s what analysts think:</strong></p>\n<figure><img decoding=\"async\" height=\"435\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-1024x435.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-1024x435.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-300x128.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-768x327.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421.png 1277w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutterstock</em></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GHRS","symbol_name":"GH Research PLC","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/05/52601688/these-analysts-revise-their-forecasts-on-gh-research-after-q1-results","article_id":"2635035358","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2635035358","pubTimestamp":1778857103,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga Earnings","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":"GH Research (NASDAQ:GHRS) reported a larger loss than expected in Q1. Analysts lowered price targets, stock fell 3.4%. CEO noted progress in GH001 program.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"GHRS":"GH Research PLC","GH":"Guardant Health Inc.","BK4588":"碎股","BK4539":"次新股","BK4585":"ETF&股票定投概念","BK4535":"淡马锡持仓","BK4196":"保健护理服务","BK4007":"制药","BK4551":"寇图资本持仓"},"translate_title":"这些分析师在第一季度业绩公布后修改了对GH Research的预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GHRS":1,"GH":1.5},"content_text":"GH Research PLC (NASDAQ:GHRS) reported a wider-than-expected loss for the first quarter on Thursday.\nThe company posted quarterly losses of 31 cents per share which missed the analyst consensus estimate of losses of 28 cents per share.\n“The first quarter of 2026 marks progress as planned toward our global GH001 Phase 3 pivotal program,” said Dr. Velichka Valcheva, Chief Executive Officer.\nGH Research shares fell 3.4% to trade at $21.46 on Friday.\nThese analysts made changes to their price targets on GH Research following earnings announcement.\n\nCitizens analyst Jason N. Butler maintained GH Research with a Market Outperform and lowered the price target from $42 to $39.\nCantor Fitzgerald analyst Charles Duncan maintained the stock with an Overweight rating and raised the price target from $25 to $35.\n\nConsidering buying GHRS stock? Here’s what analysts think:\n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}